EpiPen auto-injector for severe allergies is out of stock in Malta following Brexit uncertainty – The Headlines: The Times

The Times leads with the results from the EY Malta Attractiveness Survey published on Friday. Three-fourths of foreign investors find the country attractive to grow their business in, but more than half say that regulatory transparency and stability is a concern.

The Times says that the auto-injector for people with severe allergies, EpiPen, is out of stock in Malta following Brexit uncertainty. A GRTU spokesperson said that industry is looking at other countries where from to source the emergency treatment.

 

 

Via CiConsulta BeInformed Media Monitoring Service

Discover more from The Dispatch

Subscribe now to keep reading and get access to the full archive.

Continue reading

Verified by MonsterInsights